This brand name is authorized in Nigeria.
The drug LISITAB contains one active pharmaceutical ingredient (API):
1
|
UNII
E7199S1YWR - LISINOPRIL
|
|
Lisinopril is a peptidyl dipeptidase inhibitor. It inhibits the angiotensin-converting enzyme (ACE) that catalyses the conversion of angiotensin I to the vasoconstrictor peptide, angiotensin II. Angiotensin II also stimulates aldosterone secretion by the adrenal cortex. Inhibition of ACE results in decreased concentrations of angiotensin II which results in decreased vasopressor activity and reduced aldosterone secretion. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-6147 | Tablet | LISITAB 5MG TABLETS TAB 5 mg 2X14 | 45 CMS-PP-313180 LISITAB 5MG TABLETS LISINOPRIL 5MG Lisnopril 5mg, Magnesium Stearate, Talc Powder, Corn starch, Methy paraben. A4-6147 Drugs Nigerian Products 214 POM 1 2/4/2023 KCH CONSUMER HEALTHCARE LIMITED, 2B, KWAME NKRUMAH LANE, CROWN ESTATE LEKKI EPE EXPRESSWAY 8032317925 Kchconsumer@gmail.com KCH Consumer Healthcare Ltd., Plot 1-6 KCH Close, Off Atlantic Hall Expressway, Poka, Lekki Free Trade Zone, Epe, Lagos., Nigeria | 25/05/2023 |
| A4-6148 | Tablet | LISITAB 10MG TABLETS TAB 10 mg 2X14 | 46 CMS-PP-313181 LISITAB 10MG TABLETS LISNOPRIL 10MG Lisnopril 10mg. Magnesium Stearate, Talc powder, Corn Starch, Methy paraben. A4-6148 Drugs Nigerian Products 214 POM 1 2/4/2023 KCH CONSUMER HEALTHCARE LIMITED, 2B, KWAME NKRUMAH LANE, CROWN ESTATE LEKKI EPE EXPRESSWAY 8032317925 Kchconsumer@gmail.com KCH Consumer Healthcare Ltd., Plot 1-6 KCH Close, Off Atlantic Hall Expressway, Poka, Lekki Free Trade Zone, Epe, Lagos., Nigeria | 25/05/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C09AA03 | Lisinopril | C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-6147, A4-6148 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.